 |
Aceragen
Last updated: January 16, 2024
CEO John Taylor
Country: USA | Funding: $35M (+)
Website: http://www.aceragen.com/
Aceragen is a biopharmaceutical company with a focus on rare illnesses hopes to be the first to find a treatment for Farber disease.
Website: http://www.aceragen.com/
Aceragen is a biopharmaceutical company with a focus on rare illnesses hopes to be the first to find a treatment for Farber disease.
